Kyto Biopharma, Inc. Announces Management Changes
Corporation. Simon P. Westbrook has been appointed Chief Financial Officer of the Corporation. Peter Prendergast has resigned as Director of the Corporation.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1 USD | -45.65% | -.--% | -.--% |
1st Jan change | Capi. | |
---|---|---|
-.--% | 16.33M | |
+5.43% | 77.66B | |
+1.64% | 44.99B | |
-1.02% | 37.01B | |
+5.81% | 35.47B | |
-23.64% | 11.74B | |
+14.88% | 10.15B | |
-26.76% | 8.13B | |
+14.29% | 7.41B | |
-4.68% | 7.49B |